Evaluation of AcrySof IQ Vivity Extended Vision Intraocular Lenses

NAWithdrawnINTERVENTIONAL
0
Timeline

Start Date

June 30, 2025

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions
AphakiaPresbyopiaResidual Refractive Cylinder
Interventions
DEVICE

AcrySof IQ Vivity Extended Vision IOL

UV-absorbing, with or without blue light filtering, foldable IOL implanted in the capsular bag of the eye for the visual correction of aphakia in adult patients from whom a cataractous lens has been removed. The IOL mitigates the effects of presbyopia by providing an extended depth of focus. The toric models in addition reduce residual refractive astigmatism in patients with pre-existing corneal astigmatism.

Trial Locations (1)

76134

Contact Alcon Call Center for Trial Locations, Fort Worth

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Alcon Research

INDUSTRY

NCT06541795 - Evaluation of AcrySof IQ Vivity Extended Vision Intraocular Lenses | Biotech Hunter | Biotech Hunter